288 related articles for article (PubMed ID: 28867761)
1. SMAD2 Inactivation Inhibits CLDN6 Methylation to Suppress Migration and Invasion of Breast Cancer Cells.
Lu Y; Wang L; Li H; Li Y; Ruan Y; Lin D; Yang M; Jin X; Guo Y; Zhang X; Quan C
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867761
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation of claudin-6 promotes breast cancer cell migration and invasion by recruiting MeCP2 and deacetylating H3Ac and H4Ac.
Liu Y; Jin X; Li Y; Ruan Y; Lu Y; Yang M; Lin D; Song P; Guo Y; Zhao S; Dong B; Xie Y; Dang Q; Quan C
J Exp Clin Cancer Res; 2016 Jul; 35(1):120. PubMed ID: 27461117
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor β inhibits breast cancer cells migration and invasion through CLDN6-mediated autophagy.
Song P; Li Y; Dong Y; Liang Y; Qu H; Qi D; Lu Y; Jin X; Guo Y; Jia Y; Wang X; Xu W; Quan C
J Exp Clin Cancer Res; 2019 Aug; 38(1):354. PubMed ID: 31412908
[TBL] [Abstract][Full Text] [Related]
4. CLDN6 Suppresses Migration and Invasion of MCF-7 and SKBR-3 Breast Cancer Cells by Blocking the SMAD/Snail/MMP-2/9 Axis.
Liu T; Jiang L; Bai Q; Wu S; Yu X; Wu T; Wang J; Zhang X; Li H; Zhao K; Wang L
Bull Exp Biol Med; 2023 Jul; 175(3):376-381. PubMed ID: 37566248
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
6. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.
Zhao Z; Fan X; Jiang L; Xu Z; Xue L; Zhan Q; Song Y
J Genet Genomics; 2017 Feb; 44(2):75-84. PubMed ID: 28161325
[TBL] [Abstract][Full Text] [Related]
7. miR-148-3p Inhibits Growth of Glioblastoma Targeting DNA Methyltransferase-1 (DNMT1).
Li Y; Chen F; Chu J; Wu C; Li Y; Li H; Ma H
Oncol Res; 2019 Aug; 27(8):911-921. PubMed ID: 30982493
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells.
Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD
Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045
[TBL] [Abstract][Full Text] [Related]
9. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer.
Yan LX; Liu YH; Xiang JW; Wu QN; Xu LB; Luo XL; Zhu XL; Liu C; Xu FP; Luo DL; Mei P; Xu J; Zhang KP; Chen J
Int J Oncol; 2016 Feb; 48(2):471-84. PubMed ID: 26676464
[TBL] [Abstract][Full Text] [Related]
10. CLDN6-mediates SB431542 action through MMPs to regulate the invasion, migration, and EMT of breast cancer cells.
Li X; Li H; Liu C; Leng X; Liu T; Zhang X; Bai Q; Wang L
Int J Clin Exp Pathol; 2020; 13(7):1590-1600. PubMed ID: 32782677
[TBL] [Abstract][Full Text] [Related]
11. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
12. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
13. The interaction between miR‑148a and DNMT1 suppresses cell migration and invasion by reactivating tumor suppressor genes in pancreatic cancer.
Hong L; Sun G; Peng L; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2018 Nov; 40(5):2916-2925. PubMed ID: 30226601
[TBL] [Abstract][Full Text] [Related]
14. CLDN6 promotes chemoresistance through GSTP1 in human breast cancer.
Yang M; Li Y; Shen X; Ruan Y; Lu Y; Jin X; Song P; Guo Y; Zhang X; Qu H; Shao Y; Quan C
J Exp Clin Cancer Res; 2017 Nov; 36(1):157. PubMed ID: 29116019
[TBL] [Abstract][Full Text] [Related]
15. GALNT14 mediates tumor invasion and migration in breast cancer cell MCF-7.
Huanna T; Tao Z; Xiangfei W; Longfei A; Yuanyuan X; Jianhua W; Cuifang Z; Manjing J; Wenjing C; Shaochuan Q; Feifei X; Naikang L; Jinchao Z; Chen W
Mol Carcinog; 2015 Oct; 54(10):1159-71. PubMed ID: 24962947
[TBL] [Abstract][Full Text] [Related]
16. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells.
Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J
Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
18. MiR-29a inhibits invasion and metastasis of cervical cancer via modulating methylation of tumor suppressor SOCS1.
Gong Y; Wan JH; Zou W; Lian GY; Qin JL; Wang QM
Future Oncol; 2019 May; 15(15):1729-1744. PubMed ID: 31038361
[No Abstract] [Full Text] [Related]
19. S100A11 promotes TGF-β1-induced epithelial-mesenchymal transition through SMAD2/3 signaling pathway in intrahepatic cholangiocarcinoma.
Zhang M; Zheng S; Jing C; Zhang J; Shen H; Xu X; Lin J; Zhang B
Future Oncol; 2018 Apr; 14(9):837-847. PubMed ID: 29569474
[TBL] [Abstract][Full Text] [Related]
20. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation.
Tu CF; Wu MY; Lin YC; Kannagi R; Yang RB
Breast Cancer Res; 2017 Oct; 19(1):111. PubMed ID: 28982386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]